#evolus

Not every wrinkle needs to be “filled.”

Dr. Ron Shelton’s signature technique with Evolysse™ by Evolus focuses on rebuilding the dermal foundation.

By injecting hyaluronic acid smoothly throughout the dermis — using his unique lattice approach — the skin is fortified from within, restoring natural volume and bounce.

The result? The raisin turns back into the grape.

For consultations, please call (212) 593-1818 or book online: https://www.thenyac.com/book-a-consultation/

Not every wrinkle needs to be “filled.”

Dr. Ron Shelton’s signature technique with Evolysse™ by Evolus focuses on rebuilding the dermal foundation.

By injecting hyaluronic acid smoothly throughout the dermis — using his unique lattice approach — the skin is fortified from within, restoring natural volume and bounce.

The result? The raisin turns back into the grape.

Observe Q3: 2025-11-05 Earnings Abstract EPS of -$0.15 beats by $0.04  | Income of $68.97M (12.90% Y/Y) beats by $1.55M Evolus, Inc. (EOLS) Q3 2025 Earnings Name November 5, 2025 4:30 PM EST Firm Individuals Nareg Sagherian – Head of International Investor Relations & Company CommunicationsDavid Moatazedi – President, CEO & DirectorRui Avelar – Chief Medical Officer and Head of Analysis &…

Observe Q3: 2025-11-05 Earnings Abstract EPS of -$0.15 beats by $0.04  | Income of $68.97M (12.90% Y/Y) beats by $1.55M The next slide deck was printed by Evolus, Inc. together with their 2025 Q3 earnings name. This text was written by Observe Looking for Alpha’s transcripts group is liable for the event of all of our transcript-related tasks. We at the moment publish 1000’s of quarterly…

Evolus – A Barely Dangerous Purchase Forward Of Q2 Earnings